Introduction {#Sec1}
============

Renal tubulointerstitial injury, a major pathological change of renal senescence, is characterized by tubular atrophy, tubulointerstitial fibrosis, renal function impairment and inflammatory cell infiltration. Renal tubulointerstitial injury is a pivotal event in the common progression pathway of chronic kidney diseases^[@CR1]--[@CR3]^.

Stress-induced premature senescence (SIPS) is cellular senescence that can be induced rapidly in response to damage or cellular stress signals independent of replicative senescence. Signals include oxidative stress, DNA damage and mitochondrial injury through the p16^INK4a^ (hereafter termed p16)/retinoblastoma (Rb) pathway or p19^AFR^ (hereafter termed p19)/p53 pathways^[@CR4],\ [@CR5]^. The cell cycle regulator and tumor suppressor p16 is a biomarker, effector and regulator of aging program. P16 is also a premier indicator of the presence of senescent cells. It is often transcriptionally activated in cells undergoing irreversible senescence, which leads to aging-associated impaired function and regenerative capacity^[@CR6]--[@CR8]^. Cellular senescence causes aging-associated pathological changes and increases vulnerability to death primarily through restricting stem cell proliferation and promoting a senescence-associated secretory phenotype (SASP)^[@CR9]^. Senescent cells have deleterious effects on the tissue microenvironment. The most significance effect is the acquisition of SASP, which turns senescent fibroblasts into pro-inflammatory cells that induce an epithelial-to-mesenchymal transition (EMT) in nearby epithelial cells^[@CR10],\ [@CR11]^. Renal tubulointerstitial injury is caused by the EMT induced primarily by the transforming growth factor-β1 (TGF-β1)/Smad signal pathway, and pro-inflammatory factors derived from SASP^[@CR12]--[@CR14]^. A study has shown that the development of premature senescence was induced by p16, which is a critical regulator of cell aging and contributes to development of postischemic interstitial fibrosis and tubular atrophy^[@CR15]^. However, it is unclear whether *p16* overexpression leads to renal tubulointerstitial injury by promoting SASP of senescent renal fibroblasts and subsequent EMT of renal tubular epithelial cells.

B lymphoma moloney murine leukemia virus insertion region 1 (Bmi-1), a member of the polycomb family of transcriptional repressors, is involved in cell cycle regulation and cell senescence. Bmi-1 inhibits the p16/Rb and p19/p53 pathways and maintains mitochondrial function and redox balance^[@CR14],\ [@CR16]--[@CR19]^. Consistent with the typical histological and functional hallmarks of a SIPS model, the phenotypic features of *Bmi*-*1*-deficient mice are persistent accumulation of ROS. ROS results from impaired mitochondrial function and imbalanced redox and is sufficient to induce senescence via DNA damage^[@CR4],\ [@CR19]--[@CR21]^. Our previous evidence demonstrated that *Bmi*-*1* deficiency results in renal tubulointerstitial injury that is not fully rescued by antioxidant treatment^[@CR14]^. *Bmi*-*1* deficiency leads to excessive accumulation of *p16* mRNA and protein in the kidney^[@CR14]^. A recent study has shown that clearance of *p16*-positive cells attenuates aging-related deterioration of the kidney without apparent side effects, and also preserves glomerulus functionality^[@CR8]^. However, it is unclear whether *p16* deletion ameliorates renal tubulointerstitial injury by inhibiting SASP in *Bmi*-*1*-deficient mice.

To answer this question, compound mutant mice with homozygous deletion of both *Bmi*-*1* and *p16* (*Bmi*-*1* ^−/−^ *p16* ^−/−^) were generated, their renal phenotypes were compared with *Bmi*-*1* ^−/−^ and wild-type (WT) mice using histopathological and molecular techniques. *In vitro*, *Bmi*-*1* was knocked down in human renal proximal tubular epithelial (HK2) cells using shRNA. The effect of *Bmi-1* knock-down on the proliferation, ATP production and EMT of tubular epithelial cells were examined.

Results {#Sec2}
=======

Impaired renal structure and function ameliorated by *p16* deletion in *Bmi*-*1*^−/−^ mice {#Sec3}
------------------------------------------------------------------------------------------

To examine if *p16* deletion ameliorated impairment of renal structure and function in *Bmi*-*1* ^−/−^ mice, renal structure parameters including kidney sizes, and cortex/total, medulla/total and cortex/medulla renal thickness ratios, and glomerular number, and renal function parameters including renal peak systolic velocity (PSV), mRNA expression levels for renal *1α*-*hydroxylase* (*1α\[OH\]ase*) and *erythropoietin* (*EPO*), hematocrit percentage, levels of serum creatinine clearance (SCrCl), urine creatinine (UCr), serum urea nitrogen (SUN), serum creatinine (SCr) and urinary albumin (UAL) were examined in 5-week-old *Bmi*-*1* ^−/−^, *Bmi*-*1* ^−/−^ *p16* ^−/−^ and WT mice. Kidney sizes were significantly decreased in *Bmi*-*1* ^−/−^ mice, compared with WT mice (Fig. [1a](#Fig1){ref-type="fig"}). The cortex/total and cortex/medulla thickness ratios were decreased; however, the medulla/total thickness ratio was not altered in *Bmi*-*1* ^−/−^ mice compared with WT mice (Fig. [1b--c](#Fig1){ref-type="fig"}). Glomerular number was decreased in *Bmi*-*1* ^−/−^ mice compared with WT mice (Fig. [1d--e](#Fig1){ref-type="fig"}). Deletion of *p16* significantly rescued the renal structure abnormalities caused by *Bmi*-*1* deficiency (Fig. [1a--e](#Fig1){ref-type="fig"}). Compared with WT mice, renal PSV, mRNA for renal *1α*(*OH*)*ase* and *EPO*, hematocrit percentage, and levels of SCrCl and UCr were decreased, whereas levels of SUN, SCr and UAL were increased significantly in *Bmi*-*1* ^−/−^ compared with WT mice (Fig. [1f--n](#Fig1){ref-type="fig"}). *P16* deletion was largely rescued the renal dysfunction caused by *Bmi*-*1* deficiency.Figure 1*P16* deletion improved impaired renal structure and function in *Bmi*-*1* ^−/−^ mice. (**a**) Representative kidneys from 5-week-old *Bmi*-*1* ^−/−^, *Bmi*-*1* ^−/−^ *p16* ^−/−^ and WT mice. (**b**) Representative micrographs of kidney longitudinal sections stained with HE. (**c**) Thickness ratios for cortex/total, medulla/total and cortex/medulla. (**d**) Representative micrographs of renal cortex stained with HE. (**e**) Glomerular number relative to WT mice was determined in HE-stained sections. (**f**) Color Doppler flow imaging of peak systolic velocity (PSV) for kidneys from 5-week-old *Bmi*-*1* ^−/−^, *Bmi*-*1* ^−/−^ *p16* ^−/−^ and WT mice. (**g**) PSV measurements. (**h**) *1α*-*hydroxylase* (*1α*(*OH*)*ase*) and *erythropoietin* (*EPO*) mRNA in kidneys by real-time RT-PCR calculated as a ratio to *GAPDH* mRNA and expressed relative to WT. (**i**) Hematocrit percentages. (**j**) Serum creatinine clearance (SCrCl) levels relative to WT; (**k**) urine creatinine (UCr); (**l**) serum urea nitrogen (SUN) concentrations; (**m**) serum creatinine (SCr) levels; and (**n**) urinary albumin (UAL) levels determined by spectrophotometry. Six mice per group were used for these experiments. Values are means ± SEM of six determinations per group. \*P \< 0.05, \*\*P \< 0.05, \*\*\*P \< 0.001 compared with group; ^\#^P \< 0.05, ^\#\#^P \< 0.01 compared with *Bmi*-*1* ^−/−^ group.

Renal cell senescence, DNA damage and inflammatory cell infiltration ameliorated by *p16* deletion in *Bmi*-*1*^−/−^ mice {#Sec4}
-------------------------------------------------------------------------------------------------------------------------

To determine if the rescue of renal atrophy and renal dysfunction by *p16* deletion was associated with alterations of cell proliferation, apoptosis, senescence, DNA damage and inflammatory cell infiltration, kidneys were examined by immunohistochemistry for Ki67, TUNEL staining for apoptotic detection, and histochemistry for senescence-associated-β-gal (SA-β-gal), immunohistochemistry for 8-hydroxydeoxyguanosine (8-OHdG) as a DNA damage marker, CD3 as a T cell marker and F4/80 as a macrophage marker. Results showed that the percentage of Ki67-positive cells (Fig. [2a and g](#Fig2){ref-type="fig"}) was decreased dramatically, whereas the percentage of TUNEL-positive cells (Fig. [2b and h](#Fig2){ref-type="fig"}), SA-β-gal positive areas (Fig. [2c and i](#Fig2){ref-type="fig"}), 8-OHdG-positive cells (Fig. [2d and j](#Fig2){ref-type="fig"}), CD3-positive (Fig. [2e and k](#Fig2){ref-type="fig"}) and F4/80-positive inflammatory cells (Fig. [2f and l](#Fig2){ref-type="fig"}) were significantly increased in *Bmi*-*1* ^−/−^ mice compared with WT mice. *P16* deletion was significantly rescued the abnormalities in renal cell proliferation, apoptosis and senescence, DNA damage and inflammatory cell infiltration observed in *Bmi*-*1* ^−/−^ mice (Fig. [2a--l](#Fig2){ref-type="fig"}).Figure 2*P16* deletion improved renal aging and associated inflammatory cell infiltration in *Bmi*-*1* ^−/−^ mice. Representative micrographs of paraffin-embedded kidney sections stained immunohistochemically for (**a**) Ki67 and (**b**) TUNEL; histochemically for (**c**) senescence associated-β-galactosidase (SA-β-gal); and immunohistochemically for (**d**) 8-hydroxyguanosine (8-OHdG), (**e**) CD3 and (**f**) F4/80. Percentage of (**g**) Ki67-positive cells, (**h**) TUNEL-positive cells, (**i**) SA-β-gal-positive area, or cells positive for (**j**) 8-OHdG, (**k**) CD3, or (**l**) F4/80 relative to total cells or area. Six mice per group were used for these experiments. Values are mean ± SEM from 6 determinations per group. \*P \< 0.05, \*\*P \< 0.01, \*\*\*P \< 0.001 compared with WT group; ^\#^P \< 0.05, ^\#\#^P \< 0.01, ^\#\#\#^P \< 0.001 compared with *Bmi*-*1* ^−/−^ group.

Senescence-associated pro-inflammatory secretory phenotype ameliorated by *p16* deletion in *Bmi*-*1*^−/−^ mice {#Sec5}
---------------------------------------------------------------------------------------------------------------

To investigate if *p16* deletion ameliorated the senescence-associated pro-inflammatory secretory phenotype occurred in *Bmi*-*1* ^−/−^ mice, the expression levels of interleukin (IL)-1β, IL-6, tumor necrosis factor (TNF)-α and nuclear factor (NF)-κB-p65 at mRNA and protein levels in kidneys were examined by real-time RT-PCR and immunohistochemistry or Western blots respectively. Results showed that percentages of positive areas for IL-1β, IL-6 and TNF-α and NF-κB-p65-positive cells, the expression of *IL*-*1*β, *IL*-*6*, *TNF*-α and *NF*-κ*B* at mRNA levels, and IL-1β, IL-6, TNF-α, NF-κB-p65 and NF-κB-p65 (phospho T435) in protein levels were increased significantly in *Bmi*-*1* ^−/−^ mice compared with WT mice, however, they were reduced significantly in *Bmi*-*1* ^−/−^ *p16* ^−/−^ mice compared with *Bmi*-*1* ^−/−^ mice (Fig. [3](#Fig3){ref-type="fig"}). These results demonstrated that *p16* deletion ameliorated the pro-inflammatory secretory phenotype caused by Bmi-1 deficiency.Figure 3*P16* deletion improved senescence-associated pro-inflammatory secretory phenotype in *Bmi*-*1* ^−/−^ mice. Representative micrographs of paraffin-embedded kidney sections stained immunohistochemically for (**a**) IL-1β, (**b**) IL-6, (**c**) TNF-α and (**d**) NF-κB-p65. Percentage of (**e**) IL-1β positive area, (**f**) IL-6 positive area, (**g**) TNF-α positive area or (**h**) NF-κB-p65 positive cells relative to total cells or area. (**i**) *IL*-*1β*, *IL*-*6*, *TNF*-α and *NF*-κ*B* mRNA levels in kidneys by real-time RT-PCR, calculated as ratio to *GAPDH* mRNA and expressed relative to WT. (**j**) Western blots of kidney extracts showing IL-1β, IL-6, TNF-α, NF-κB-p65 and NF-κB-p65 (phospho T435). β-actin was the loading control. (**k**) Protein levels relative to β-actin were assessed by densitometric analysis. Six mice per group were used for these experiments. Values are mean ± SEM from six determinations per group. \*P \< 0.05, \*\*P \< 0.01, \*\*\*P \< 0.001 compared with WT group; ^\#^P \< 0.05, ^\#\#^P \< 0.01 compared with *Bmi*-*1* ^−/−^ group.

Tubulointerstitial injury ameliorated by *p16* deletion in *Bmi*-*1*^−/−^ mice {#Sec6}
------------------------------------------------------------------------------

To determine if *p16* deletion improved tubulointerstitial injury in *Bmi*-*1* ^−/−^ mice, kidneys were examined histochemically for Masson's trichrome (Masson)-labeled interstitial fibers, immunohistochemically for E-cadherin, activated TGF-β1, type I collagen (Col-I) and α-SMA, electron microscopy for tubulointerstitium, and Western blots for E-cadherin, α-SMA, TGF-β1 precursor, activated TGF-β1, TGF-β receptor II (TGF-βRII), Smad2 and pSmad2/3. In *Bmi*-*1* ^−/−^ mice compared with WT mice, significant increases were observed in the percentages of positive areas for activated TGF-β1, Masson-labeled interstitial fibers, Col-I and α-SMA, and protein expression levels of α-SMA, activated TGF-β1, TGF-βRII, Smad2 and pSmad2/3, whereas the percentage of E-cadherin-positive areas and E-cadherin protein expression levels were decreased (Fig. [4](#Fig4){ref-type="fig"}). Electron micrographs showed fibroblasts and collagen fibrils in the renal tubulointerstitium of *Bmi*-*1* ^−/−^ mice (Fig. [4k](#Fig4){ref-type="fig"}). *P16* deletion significantly rescued tubulointerstitial injury caused by Bmi-1 deficiency (Fig. [4](#Fig4){ref-type="fig"}).Figure 4*P16* deletion improved senescence-associated pro-fibrotic secretory phenotype and tubulointerstitial injury in *Bmi*-*1* ^−/−^ mice. Representative micrographs of paraffin-embedded kidney sections stained immunohistochemically for (**a**) E-cadherin and (**b**) activated transforming growth factor-β1 (TGF-β1); histochemically for (**c**) Masson's trichrome (Masson), and immunohistochemically for (**d**) type Ι collagen (Col-I) and (**e**) α-smooth muscle actin (α-SMA). Percentage of (**f**) E-cadherin positive area, (**g**) activated TGF-β1 positive area, (**h**) interstitial fiber positive area demonstrated by Masson's trichrome stain, (**i**) Col-I positive area and (**j**) α-SMA positive area. (**k**) Electron micrograph of kidney sections from *Bmi*-*1* ^−/−^, *Bmi*-*1* ^−/−^ *p16* ^−/−^ and WT mice. Blue arrows: fibroblasts; yellow arrows: collagen fibrils; red arrows: hemorrhage in renal tubulointerstitium. (**l**) Western blots of kidney extracts for E-cadherin, TGF-β1, α-SMA, TGF-β1 precursor, activated TGF-β1, transforming growth factor-β receptor II (TGF-βRII), Smad2 and pSmad2/3 (Ser423/425). β-actin was the loading control. (**m**) Protein relative to β-actin was assessed by densitometric analysis. Six mice per group were used for these experiments. Values are mean ± SEM from six determinations per group. \*P \< 0.05, \*\*P \< 0.01, \*\*\*P \< 0.001 compared with WT group; ^\#^P \< 0.05, ^\#\#^P \< 0.01, ^\#\#\#^P \< 0.001 compared with *Bmi*-*1* ^−/−^ group.

Mitochondrial respiration and proliferative capacity in HK2 cells were reduced by *Bmi*-*1* knocked down {#Sec7}
--------------------------------------------------------------------------------------------------------

To determine effect of Bmi-1 on the function of HK2 cells, we generated a *Bmi*-*1* knock-down HK2 cell lines using short hairpin RNA (shRNA). Silencing efficiencies in HK2 cells were 73.67% for human *Bmi*-*1*-specific shRNA and 85.33% for negative control (NC)-shRNA (Fig. [5a,b](#Fig5){ref-type="fig"}). In *Bmi*-*1* shRNA-transfected HK2 cells, *Bmi*-*1* gene expression was down-regulated to 21.12% and protein was down-regulated to 29.36% of NC groups (Fig. [5c--e](#Fig5){ref-type="fig"}). These results demonstrated that *Bmi*-*1* was knocked down successfully in a stable transfection of HK2 cells with *Bmi*-*1* shRNA.Figure 5Human *Bmi*-*1* shRNA knocked down Bmi-1 in HK2 cells *in vitro*. (**a**) Representative micrographs of HK2 cells from human *Bmi*-*1*-specific shRNA (Bmi-1 shRNA) and negative control-shRNA (NC) groups by fluorescence microscopy in fluorescence-field for EGFP positive or bright field. (**b**) Transfection efficiency was measured as percentage EGFP-positive cells relative to total cells, 4 days after transfection. (**c**) Human *Bmi*-*1* mRNA in HK2 cells from NC and *Bmi*-*1* shRNA-transfected cells determined by real time RT-PCR as a ratio to *GAPDH* mRNA, relative to NC. (**d**) Western blots of HK2 extracts showing Bmi-1. β-actin was the loading control. (**e**) Bmi-1 protein relative to β-actin assessed by densitometric analysis. (**f**) ATP concentration of HK2 determined by spectrophotometry. (**g**) Transfected HK2 cells proliferation determined by CCK-8 assays and spectrophotometry at 450 nm. Cell number determined on indicated hours is presented relative to cell number at hour 0. Six biological replicates were used for these studies per experiment. Values are means ± SEM of six determinations. \*\*P \< 0.01, \*\*\*P \< 0.001 compared with NC group.

To investigate if *Bmi*-*1*-knockdown affected mitochondrial respiration in HK2 cells, ATP concentration in *Bmi*-*1*-knockdown and NC groups were examined. Compared with NC group, ATP concentration was significantly decreased in *Bmi*-*1*-knockdown group (Fig. [5f](#Fig5){ref-type="fig"}). This result demonstrated that mitochondrial respiration was reduced by *Bmi*-*1* knocked down in HK2 cells. The most striking phenotype is decreased proliferative capacity for the *Bmi*-*1*-knockdown HK2 cells compared to NC group (Fig. [5g](#Fig5){ref-type="fig"}).

EMT of *Bmi*-*1*-knockdown HK2 cells enhanced by SASP molecules from Bmi-1 deficient renal interstitial fibroblasts and ameliorated by *p16* deletion {#Sec8}
-----------------------------------------------------------------------------------------------------------------------------------------------------

Renal interstitial fibroblasts (RIFs) have a typical spindle-shaped morphology. To further determine the mesenchymal characterization of RIFs, mesenchymal cell markers α-*SMA*, *fibronectin* and *vimentin* were detected using real-time RT-PCR in the second-passage RIFs. Results showed that although they all were expressed in the second-passage RIFs from WT, *Bmi*-*1* ^−/−^ and *Bmi*-*1* ^−/−^ *p16* ^−/−^ mice, their expression levels were up-regulated significantly in *Bmi*-*1* ^−/−^ mice and returned to the normal levels in *Bmi*-*1* ^−/−^ *p16* ^−/−^ mice (Figure [S1](#MOESM1){ref-type="media"}). These results suggest that the up-regulated mesenchymal characterization of RIFs *ex vivo* might be related to the increased renal tubulointerstitium *in vivo* in *Bmi*-*1* ^−/−^ kidneys.

To investigate if *p16* deletion delayed senescence of RIFs in *Bmi*-*1* ^−/−^ mice, the fifth-passage RIFs were examined by histochemistry for SA-β-gal and by cell-counting kit-8 assays for cell proliferation from 24 to 96 hours after adherence cultures. Compared with WT mice, the percentage of SA-β-gal-positive area was significantly increased in *Bmi*-*1* ^−/−^ mice. Cell numbers relative to seeded cell numbers increased significantly from 24 to 96 hours in wild-type control cultures, but decreased from 24 to 96 hours in *Bmi*-*1* ^−/−^ cultures. Compared with *Bmi*-*1* ^−/−^ mice, the percentage of SA-β-gal-positive areas *was* significantly decreased in *Bmi*-*1* ^−/−^ *p16* ^−/−^ mice. Cell numbers relative to seeded cell numbers increased significantly from 48 to 96 hours in *Bmi*-*1* ^−/−^ *p16* ^−/−^ cultures (Fig. [6a--c](#Fig6){ref-type="fig"}). These results demonstrated that *p16* deletion delayed senescence of RIFs caused by Bmi-1 deficiency.Figure 6*P16* deletion ameliorated enhanced EMT induced by SASP of senescent renal interstitial fibroblasts. (**a**) Representative micrographs of cells stained cytochemically for senescence associated-β-galactosidase (SA-β-gal). (**b**) Percentage of SA-β-gal-positive area relative to total area. (**c**) Fifth-passage renal interstitial fibroblast proliferation determined by CCK-8 assays and spectrophotometry at 450 nm. Cell number determined on indicated hours is presented relative to cell number at hour 0. Six biological replicates were used for these studies per experiment. Values are mean ± SEM from six determinations per group. \*P \< 0.05, \*\*P \< 0.01, \*\*\*P \< 0.001 compared with WT group; ^\#^P \< 0.05, ^\#\#^P \< 0.01, ^\#\#\#^P \< 0.001 compared with *Bmi*-*1* ^−/−^ group. (**d**) *Bmi*-*1* shRNA-transfected HK2 cells sorted for EGFP; EGFP-positive HK2 cells were treated with isometric conditioned medium (CM) from renal interstitial fibroblasts and normal culture medium for 4 days and were stained immunocytochemically for α-SMA. (**e**) Percentage of α-SMA-positive cells relative to total cells. (**f**) Western blots of HK2 cell extracts showing α-SMA. β-actin was the loading control. (**g**) α-SMA protein relative to β-actin, assessed by densitometric analysis. (**h**) IL-1β, IL-6, TNF-α, or activated IL-1β concentration in CM by ELISA and assessed by densitometric analysis relative to WT CM. Six biological replicates were used for these studies per experiment. Values are mean ± SEM from six determinations per group. \*P \< 0.05, \*\*P \< 0.01, \*\*\*P \< 0.001 compared with WT CM group; ^\#^P \< 0.05, ^\#\#^P \< 0.01, ^\#\#\#^P \< 0.001 compared with *Bmi*-*1* ^−/−^ CM group.

To further assess whether SASP molecules released from *Bmi*-*1*-deficient renal interstitial fibroblasts enhanced EMT of *Bmi*-*1*-knockdown HK2 cells and whether *p16* deletion ameliorated such EMT, *Bmi*-*1*-knockdown HK2 cells were cultured for 4 days with isometric conditioned medium (CM) from the cultures of fifth-passage RIFs of *Bmi*-*1* ^−/−^, *Bmi*-*1* ^−/−^ *p16* ^−/−^ and WT mice. The expression of α-SMA was examined in the resulting cells using immunocytochemistry and Western blot. The percentage of α-SMA-positive cells and α-SMA protein expression levels were increased dramatically in *Bmi*-*1*-knockdown HK2 cells cultured with the CM from *Bmi*-*1* ^−/−^ RIFs compared with that from WT RIFs, and were decreased significantly in the cells cultured with the CM from *Bmi*-*1* ^−/−^ *p16* ^−/−^ RIFs (Fig. [6d--g](#Fig6){ref-type="fig"}). These results demonstrated that SASP molecules released from *Bmi*-*1* deficient renal interstitial fibroblasts enhanced EMT of *Bmi*-*1*-knockdown HK2 cells, whereas *p16* deletion could ameliorate such EMT of *Bmi*-*1*-knockdown renal tubular epithelial cells.

To determine if *p16* deletion inhibited the SASP molecules released from *Bmi*-*1*-deficient RIFs, protein levels were examined in the CM from cultures of fifth-passage RIFs of *Bmi*-*1* ^−/−^, *Bmi*-*1* ^−/−^ *p16* ^−/−^ and WT mice by enzyme-linked immunosorbent assay (ELISA). IL-1β, IL-6, TNF-α and activated TGF-β1 protein levels were increased significantly in the CM from *Bmi*-*1* deficient RIFs compared with that from WT RIFs, and were decreased significantly in the CM from *Bmi*-*1* ^−/−^ *p16* ^−/−^ RIFs (Fig. [6h](#Fig6){ref-type="fig"}). These results demonstrated that *p16* deletion inhibited the SASP molecules released from *Bmi*-*1*-deficient RIFs.

Exogenous recombinant human TGF-β1 enhanced EMT of *Bmi*-*1*-knockdown HK2 cells {#Sec9}
--------------------------------------------------------------------------------

To determine the effect of exogenous TGF-β1 treatment on the *Bmi*-*1* depleted renal tubular epithelial cells, *Bmi*-*1*-knockdown and NC HK2 cells were cultured for 24 h in serum-free medium in the presence or absence of 4 ng ml^−1^ recombinant human TGF-β1 and resulting cells were Immunofluorescence staining and Western blots for α-SMA and E-cadherin. The percentage of α-SMA positive cells and α-SMA protein levels were obviously increased, whereas the level of E-cadherin protein expression levels were markedly decreased in *Bmi*-*1*-knockdown HK2 cells compared with NC HK2 cells in either absence or presence of TGF-β1. The alterations of these parameters were more dramatically in both TGF-β1-treated NC and *Bmi*-*1*-knockdown HK2 cells (Fig. [7](#Fig7){ref-type="fig"}). These results demonstrated that exogenous TGF-β1 could further induce the EMT of *Bmi*-*1*-knockdown HK2 cells.Figure 7Exogenous TGF-β1 further induced the EMT of *Bmi*-*1*-knockdown HK2 cells. (**a**) Representative micrographs of HK2 cells from negative control (NC), *Bmi*-*1*-knockdown (Bmi-1 shRNA), NC treated with TGF-β1 (NC + TGF-β1), and *Bmi*-*1*-knockdown treated with TGF-β1 (Bmi-1 shRNA + TGF-β1) groups stained by immunofluoresence for α-SMA (green, 1^st^ line) with DAPI for nuclei (blue, 2^nd^ line); overlap (3^rd^ line). (**b**) Percentage of α-SMA-positive cells relative to total cells. (**c**) Western blots of these HK2 cell extracts showing E-cadherin and α-SMA. β-actin was the loading control. (**d**) α-SMA protein relative to β-actin, assessed by densitometric analysis. Six biological replicates were used for these studies per experiment. Values are mean ± SEM of six determinations per group. \*P \< 0.05; \*\*P \< 0.01; \*\*\*P \< 0.001 compared with NC group. ^\#^P \< 0.05; ^\#\#^P \< 0.01; ^\#\#\#^P \< 0.001 compared with Bmi-1 shRNA group; ^&&^P \< 0.01 compared with NC + TGF-β1 group.

Discussion {#Sec10}
==========

This study demonstrated that impaired renal structure including thinner renal cortex and decreased glomeruli, dysfunction, decreased renal cell proliferation, increased renal cell apoptosis, senescence and SASP with DNA damage, NF-kB-p65 and TGF-β1/Smad signal activation, inflammatory cell infiltration, tubulointerstitial fibrosis and tubular atrophy caused by *Bmi*-*1* deficiency were largely rescued by *p16* deletion. We also demonstrated that *p16* deletion promoted proliferation, ameliorated senescence and the SASP in RIFs, and subsequently inhibited the EMT of HK2 cells induced by *Bmi*-*1*-knockdown. Exogenous TGF-β1 further induced the EMT of *Bmi*-*1*-knockdown HK2 cells. These findings indicated that *p16* deletion could be a critical event in preventing renal tubulointerstitial injury.

Cell senescence, inclusive of replicative senescence and stress-induced premature senescence (SIPS), is both a marker of renal aging and a participating factor^[@CR5]^. *P16*, encoded by the Ink4a/Arf locus (also known as *Cdkn2a*), leads to hypo-phosphorylation of the Rb by inhibiting the activity of cyclin-dependent kinases 4 and 6. This event results in irreversible cell-cycle arrest in G1 phase and growth arrest via the effects of pRb on E2F^[@CR7],\ [@CR22],\ [@CR23]^. Previous work indicates that activation of the p53/p21 pathway is important in the initiation of senescence; however, induction of p16/Rb is required to maintain irreversible senescence^[@CR24]^.

Previous evidence and our observations suggest that *Bmi*-*1*-deficient mice are a SIPS model in which persistent accumulation of ROS results from impaired mitochondrial function and imbalanced redox, which are sufficient to induce senescence via DNA damage^[@CR14],\ [@CR18]--[@CR20]^. *Bmi*-*1*-deficient senescent renal cells have arrested growth, imbalanced proliferation/apoptosis and altered levels of secreted inflammatory factor and growth factor. These features lead to renal tubulointerstitial fibrosis, tubular atrophy and renal dysfunction^[@CR14],\ [@CR20]^. This study therefore examined if *p16* deletion rescued the renal SIPS phenotype of *Bmi*-*1*-deficient mice.

In rodents and humans, renal *p16* mRNA and protein expression correlate significantly with kidney aging^[@CR23]^. Recent studies suggest that p16-positive senescent cells that accumulate during adulthood negatively influence lifespan and promote renal age-dependent changes. Therapeutic removal of these cells may be an attractive approach to extend healthy lifespan and to delay renal aging^[@CR8]^. A typical histological feature of renal aging is decreased cortical mass^[@CR5]^. This study therefore examined if *p16* deletion rescues renal aging phenotypes caused by *Bmi*-*1* deficiency. We found that thinner renal cortex and decreased glomeruli caused by *Bmi*-*1* deficiency were improved by *p16* deletion. Thus, *p16* deletion rescued the renal cortex thickness of renal SIPS.

The characteristic functional changes of renal aging include increased renal vascular resistance, reduced renal plasma flow and increased filtration fraction^[@CR3],\ [@CR5]^. Previous studies found that glomerular filtration rate (GFR) and renal function are inversely related to the severity of increased renal tubulointerstitial fibrosis, tubular atrophy and inflammatory cell infiltration. Tubular atrophy increases fluid delivery to the macula densa and triggers a reduction in GFR via tubuloglomerular feedback. The severity of proteinuria promotes a decline in GFR^[@CR1],\ [@CR14],\ [@CR25],\ [@CR26]^. The clearance of p16-positive cells attenuates age-related increases in blood urea nitrogen and preserves glomerulus functionality^[@CR8]^. PSV is a semiquantitative measure by spectral Doppler imaging of intrarenal blood flow. PSV is strongly associated with renal vascular compliance and resistance, and correlates with renal function and histological damage scores^[@CR14],\ [@CR27],\ [@CR28]^. In this study, we found that the impaired renal function of *Bmi*-*1*-deficient kidneys was improved by *p16* deletion, including decreased PSV of renal arteries, decreased SCrCl and UCr, and increased SCr, SUN and urinary albumin from GFR reduction. We also found that down-regulated expression of *1α*(*OH*)*ase* and *EPO* genes due to weakened renal endocrine secretion in *Bmi*-*1* deficient kidneys was rescued by *p16* deletion. Thus, *p16* deletion rescued renal excretion and endocrine functions of renal SIPS.

Expression of the proliferation marker Ki67 correlates inversely with p16 in senescent kidneys of the cortex and interstitium. These findings further support p16 as an irreversible cell cycle inhibitor in renal aging^[@CR3],\ [@CR29]^. Our results also suggested that *p16* deletion increased Ki67 expression in the cortex and interstitium of *Bmi*-*1*-deficient kidneys. Renal SIPS triggers a tubular response to tubulointerstitial damage, and propagation of damage and progression of chronic kidney disease, which induces tubular cell apoptosis^[@CR1]^. Loss of cortical mass is partly determined by an imbalance between proliferation and apoptosis or senescence of renal cells. We found that *p16* deletion decreased TUNEL-positive apoptotic cells and the activity of SA-β-gal in *Bmi*-*1*-deficient kidneys. Previous studies of animal models and human kidney biopsy specimens showed that tubular epithelial cell apoptosis injury to the tubulointerstitium is related to proteinuria^[@CR1],\ [@CR3]^. Thus, *p16* deletion could reduce proteinuria and preserve renal function by maintaining the balance of proliferation and apoptosis in tubular epithelial cells of renal SIPS.

Through a positive feedback loop, DNA damage halts cell-cycle progression in senescent cells by activating p16 in a persisted lesions state. This state causes mitochondrial dysfunction and ROS production, which leads to further up-regulation of p16 and new DNA damage^[@CR9]^. Our previous results demonstrated that *Bmi*-*1* deficiency causes mitochondrial dysfunction, ROS production, DNA damage and persistent p16 up-regulation in the kidney^[@CR14]^. In this study, we found that *p16* deletion ameliorated DNA oxidative damage labeled by 8-OHdG in *Bmi*-*1*-deficient kidneys. Accumulating evidence shows that when irreversible cell-cycle arrest is triggered by severe DNA damage, SASP is provoked by strong stress in senescent cells^[@CR10]^. Chronic tissue inflammation is characterized by infiltration of macrophages and lymphocytes^[@CR30]^. Previous observations raised the possibility that senescent cells are armed with a self-elimination program that recruits T cells and macrophages due to proinflammatory, chemotactic factors secreted as part of the SASP^[@CR9],\ [@CR31]^. Several lines of evidence suggest that dedifferentiated tubular cells and senescent interstitial fibroblasts produce senescence-associated biologically active molecules including cytokines, chemokines, and other molecules. These molecules stimulate the production of more mediators, recruit inflammatory cells to the tubulointerstitium, and further promote inflammation, tubular injury and apoptosis^[@CR1],\ [@CR32]^. We believe that inflammatory cells were recruited into the tubulointerstitium by way of glomerular afferent arteries, which is induced by proinflammatory cytokines and chemokines secreted by renal senescent cells. Our results suggested that *p16* deletion decreased T cell and macrophage infiltration in the renal tubulointerstitium of renal SIPS by preventing cell aging.

To further determine the molecules secreted by senescent cells to recruit inflammatory cells into the tubulointerstitium, this study detected soluble signaling factors as the major components of the SASP. Our results indicate that *p16* deletion significantly reduced IL-1β, IL-6 and TNF-α secretion in *Bmi*-*1*-deficient kidneys. IL-6, a pleiotropic pro-inflammatory cytokine and the most prominent cytokine of the SASP, increases after DNA damage-induced senescence in mouse and human fibroblasts and epithelial cells. IL-6 also initiates inflammatory responses^[@CR33],\ [@CR34]^. IL-1β is overexpressed and secreted by senescent endothelial cells, fibroblasts and epithelial cells. These cells affect neighboring cells through IL-1 receptor/Toll-like receptor superfamily cell-surface receptors to trigger NF-κB^[@CR10]^. TNF-α is associated with inflammation, aging, age-related diseases, and cellular senescence^[@CR35]^. NF-κB, a transcription factor activated by cellular damage and stress, has increased activity with aging and aging-related chronic diseases^[@CR36]^. The SASP is largely initiated by NF-κB signaling^[@CR31],\ [@CR36]^. Expression of many SASP components depends on NF-κB activity^[@CR33]^. NF-κB knockdown significantly decreases the levels of 75% of SASP factors^[@CR33]^. Thr435 phosphorylation of promoter-bound p65 can be stimulated by TNF-α, which modulates interactions with HDAC1, controls the specificity of NF-κB activity, and selectively regulates NF-κB-dependent gene expression of SASP components^[@CR10],\ [@CR37],\ [@CR38]^. Our study demonstrated that *p16* deletion ameliorated the up-regulated NF-κB gene and NF-κB-p65 and NF-κB-p65 (phospho T435) protein levels caused by Bmi-1 deficiency. Thus, *p16* deletion inhibited SASP through down-regulating NF-κB pro-inflammatory signaling in renal SIPS.

The typical histological features of renal aging are decreased cortical mass with corresponding increases in interstitial fibrosis and tubular atrophy^[@CR39]^. Renal fibrosis is characterized by transition of tubular epithelial cells into cells with mesenchymal features. This EMT is fundamentally linked to the pathogenesis of renal interstitial fibrosis^[@CR12],\ [@CR40]^. Our previous study demonstrated that *Bmi*-*1* deficiency induces renal tubular epithelial cells in the mesenchymal transition, including up-regulating α-SMA expression and down-regulating E-cadherin expression^[@CR14]^. Previous evidence suggest that up-regulation of p16 has a positive relationship with the degree of EMT in obstructed kidneys that is similar to renal aging and many kidney diseases^[@CR41]^. Our study demonstrated that *p16* deletion ameliorated EMT in *Bmi*-*1*-deficient kidneys. Of the many factors that regulate EMT, TGF-β1 is the most potent inducer of initiating and completing the EMT course and acts mainly through the TGF-β1/Smad signal pathway by activation of Smad2/3^[@CR12],\ [@CR14],\ [@CR41]^. Thus, the EMT program seems to be a viable therapeutic strategy for protecting the functional parenchyma in kidney fibrosis^[@CR12]^. Our previous study revealed that TGF-β1/Smad signaling is activated in *Bmi*-*1*-deficient kidneys, including significant up-regulation of active TGF-β1, pSmad2/3, Smad4 and TGF-β1 type II receptor (TGF-βRII)^[@CR14]^. P16 positively correlates with TGF-*β*1/Smad2/3 in unilateral ureteral obstruction mice^[@CR41]^. This study showed that *p16* deletion inhibited TGF-β1/Smad signaling including down-regulation of activated TGF-β1, TGF-βRII and pSmad2/3 in *Bmi*-*1*-deficient kidneys. Thus, *p16* deletion might inhibit EMT by down-regulating TGF-β1/Smad signaling in renal SIPS.

Several lines of evidence suggest that SASP components such as IL-6 stimulate tissue fibrosis in certain epithelial tissues by inducing EMT. SASP components also intensify age-related tissue deterioration by spreading senescence paracrines of senescent cells such as IL-1β, TGF-β1 and certain chemokine ligands to healthy neighboring cells^[@CR15]^. Our study found that senescent interstitial cells from *Bmi*-*1*-deficient kidneys induced EMT in epithelial cells knocked down for *Bmi*-*1* by secreting SASP components including IL-1β, IL-6 and TNF-α, and activated TGF-β1. Due to the most potent induction of TGF-β1 and the protective effect of Bmi-1 in the EMT course^[@CR12],\ [@CR14],\ [@CR42],\ [@CR43]^, we analyzed the effect of exogenous TGF-β1 on the *Bmi*-*1* depleted renal tubular epithelial cells. We found that TGF-β1 further induced the EMT of *Bmi*-*1* depleted renal tubular epithelial cells. These results suggest that TGF-β1 produced by senescent interstitial fibroblasts might play a critical role in inducing EMT of tubular epithelial cells in *Bmi*-*1*-deficient kidneys. *P16* deletion inhibited EMT in renal epithelial cells by decreasing secretion of SASP components in renal SIPS.

As a critical regulator of renal cell aging and a widely used biomarker of senescent cells, *p16* is often transcriptionally activated in cells undergoing irreversible senescence, which leads to aging-associated impaired function and regenerative capacity^[@CR8],\ [@CR15],\ [@CR44]^. Thus, it is a key question to delay aging or age-related diseases that how to eliminate the p16 positive senescent cells and avoid cancer. Previous study has demonstrated that as a new class of drugs termed senolytics, dasatinib and quercetin selectively kill p16 positive senescent cells, down-regulate the expression of *p16* mRNA in kidney lysates, reduce the score of age-related pathology in kidney, and extend healthspan significantly with periodic treatment^[@CR45]^. Several lines of recent evidence also suggest that as potent senolytic drugs, ABT263, UBX0101 and AP20187 also selectively cleared p16 positive senescent cells by inducing apoptosis and decreased the expressions of *p16* mRNA and protein^[@CR44],\ [@CR46]^. In this study, *p16* deletion largely rescued renal cellular senescence and ameliorated the renal tubulointerstitial injury caused by *Bmi*-*1* deficiency.

In summary, our results demonstrated that *Bmi*-*1* deficiency resulted in up-regulated p16/Rb-pathway-mediated renal cellular senescence induced by some pathologic stresses including DNA damage and mitochondrial injury. Senescent renal cells had arrested growth and imbalance of proliferation/apoptosis, and SASP. Renal tubulointerstitial injury resulted from SASP including inflammatory cell infiltration induced by NF-κB signal, and EMT induced by TGF-β1/Smad signal activation. However, *p16* deletion largely rescued renal aging phenotypes caused by *Bmi*-*1* deficiency (Table [1](#Tab1){ref-type="table"}). *P16* deletion also promoted proliferation, reduced senescence and SASP of RIFs and subsequently inhibited EMT of *Bmi*-*1*-knockdown HK2 cells. Thus, *p16* positive senescent cells would be a therapeutic target for preventing renal tubulointerstitial injury.Table 1*P16* ^*INK4a*^ deletion largely rescued renal aging phenotypes caused by *Bmi*-*1* deficiency.ParametersBmi-1 KO/WTDKO/Bmi-1 KORenal structure↓↓↑Renal function↓↓↑Renal cell proliferation↓↓↑Renal cell apoptosis & senescence↑↑↓DNA damage↑↑↓Inflammatory cell infiltration↑↑↓SASP↑↑↓NF-κB &TGF-β1 signaling activation↑↑↓EMT↑↑↓Tubulointerstial injury↑↑↓↓: presents reduction or inhibition; ↑: presents increase or enhancement.

Experimental Procedures {#Sec11}
=======================

Mice and genotyping {#Sec12}
-------------------

Bmi-1 homozygotes (*Bmi*-*1* ^−/−^) (129Ola/FVB/N hybrid background) and WT littermates were generated and genotyped as described previously^[@CR14],\ [@CR18],\ [@CR20]^. *P16* ^*Ink4*^α^+/−^ mice of the FVB N2 background were crossed to *Bmi*-*1* ^+/−^ mice to generate double-knockout (*Bmi*-*1* ^−/−^ *p16* ^−/−^) mice and genotyped as described previously^[@CR14]^. Five-week-old *Bmi*-*1* ^−/−^, *Bmi*-*1* ^−/−^ *p16* ^−/−^ and WT mice were used for experiments. This study was carried out in strict accordance with the guidelines of the Institute for Laboratory Animal Research of Nanjing Medical University in Nanjing of China. The protocol was approved by the Committee on the Ethics of Animal Experiments of Nanjing Medical University (Permit Number: IACUC-1706001).

HK2 cell culture {#Sec13}
----------------

The HK2 cells (human renal proximal tubular epithelial cell line) (American Type Culture Collection, Manassas, VA, USA), were cultured in 1640 medium supplemented with 10% fetal bovine serum (FBS), 100 U ml^−1^ penicillin, 100 µg ml^−1^ streptomycin and 2 mM L-glutamine (Gibco, Grand Island, NY, USA) until \~90% confluent^[@CR14],\ [@CR47]^.

Renal interstitial fibroblast cultures {#Sec14}
--------------------------------------

Kidneys were separated from fibrous capsules using blunt dissection and rinsed three times in phosphate buffered saline (PBS) (0.01 mM PO~4~ ^3−^, pH 7.4) containing penicillin and streptomycin (200 U ml^−1^ penicillin and 200 μg ml^−1^ streptomycin). Kidneys were minced and digested for 1 hour in 1.5 mg ml^−1^ collagenase D (Roche Diagnostics GmbH, Mannheim, BW, Germany) at 175 rpm in a constant temperature shaker at 37 °C and centrifuged with 1500 rpm for 5 min at 37 °C. Supernatants were discarded and pellets were washed with PBS and centrifuged repeatedly^[@CR20],\ [@CR48]^. Pellets were resuspended in 10 ml normal culture medium of α-minimum essential medium (α-MEM) containing 10% (v/v) FBS, 100 U ml^−1^ penicillin, 100 μg ml^−1^ streptomycin, 2 mM L-glutamine (Gibco) and 50 µg ml^−1^ ascorbic acid (Sigma, St. Louis, MO, USA). Cells were placed in 10-cm Petri dishes and kept in a humidified 5% CO~2~ incubator at 37 °C. Half the medium was changed every 3 days. At 90% confluence, cells were recovered for expansion using 0.25% trypsin-0.02% EDTA^[@CR20],\ [@CR48]^. Second-passage renal interstitial fibroblasts (RIFs) were detected with real-time RT-PCR for mesenchymal cell markers α-*SMA*, *fibronectin* and *vimentin* ^[@CR14],\ [@CR49]^. According to the Hayflick limitation^[@CR50]^, we repeatedly passaged the RIFs to purify them and observe senescence phenotype. Because the fifth-passage RIFs remarkably displayed senescence phenotype in *Bmi*-*1*-knockout RIFs, we used the fifth-passage RIFs in our experiments. In order to use the same generation of RIFs for our experiments, we expanded RIFs by 4 passages, then freezed and stored them in liquid nitrogen. Thawing and recovery of these cells from liquid nitrogen were used as the fifth-passage RIFs for related experiments.

Short hairpin RNA-mediated knockdown of human Bmi-1 {#Sec15}
---------------------------------------------------

Using the most effective small interference RNA target sequence^[@CR14]^, short hairpin DNA encoding short hairpin RNA (shRNA) specifically targeting human Bmi-1 (GenBank: NM_005180.8) was synthesized by GeneChem Co. Ltd., Shanghai, China and used to construct plasmid pGV248/Bmi-1-shRNA by insertion into Age I-EcoR I-linearized pGV248, an shRNA shuttle expression vector containing an enhanced green fluorescent protein (EGFP) reporter gene (GeneChem Co. Ltd.)^[@CR51]^. The negative control vector pGV248/control-shRNA was constructed similarly using an unrelated shRNA sequence that does not suppress expression of genes expressed in humans (GeneChem Co. Ltd.)^[@CR51],\ [@CR52]^. *Bmi*-*1*-knockdown was checked by DNA sequencing, which displayed in Supplementary files--DNA Sequencing. Recombinant virus was packaged using Lentivector Expression Systems (GeneChem Co. Ltd.)^[@CR51]^. HK2 cells were infected using enhanced infection solution and polybrene and cultured in RPMI-1640 medium (Gibco) containing 10% FBS according to the manufacturer's instructions^[@CR51],\ [@CR52]^. After one week, EGFP-positive cells were sorted with a BD FACS ARIA II SORP instrument (Becton-Dickinson, Mountain View, CA, USA) following manufacturer's instructions as previously described^[@CR53],\ [@CR54]^. Transfected HK2 cells were sorted by EGFP (purity, \>97%), and harvested and expanded, and mRNA and protein were detected by real-time RT-PCR or western blot. Before each related experiment, EGFP-sorted HK2 cells were transfected again. Sequences of synthesized shDNAs encoding human *Bmi-1*-specific shRNA or Negative control are in Table [S1](#MOESM1){ref-type="media"}.

Cell proliferation {#Sec16}
------------------

Cell proliferation was analyzed using cell counting kit-8 (CCK-8) assay kits (Lot C0038) (Beyotime Institute of Biotechnology, Shanghai, China)^[@CR55]^. Fifth-passage RIFs or transfected HK2 cells were seeded in 96-well plates at 2000 cells well^−1^. Fifth-passage RIFs were incubated for 0, 24, 48, 72 or 96 hours. Transfected HK2 cells were incubated for 0, 12, 24, 36 or 48 hours. CCK-8 (10 µl) was added to each well and cultures were incubated at 37 °C for 1 hour. Cells were detected by spectrophotometry at 450 nm absorbance following manufacturer's instructions and population doublings were calculated^[@CR18],\ [@CR55]^.

ATP concentration detection {#Sec17}
---------------------------

HK2 cells from *Bmi*-*1*-knockdown and negative control groups were collected and detected for ATP concentration (A095 ATP detection kit) according to the manufacturer's instructions (Nanjing Jiancheng Bioengineering Institute, China).

Exogenous recombinant human TGF-β1 treatment {#Sec18}
--------------------------------------------

HK2 cells from *Bmi*-*1*-knockdown and negative control groups were seeded at 70% confluence in 1640 medium supplemented with 5% fetal bovine serum (FBS), 100 U ml^−1^ penicillin, 100 µg ml^−1^ streptomycin and 2 mM L-glutamine. Twenty-four hours later, the cells were changed to serum-free medium with 4 ng ml^−1^ recombinant human TGF-β1 (Novoprotein Scientific Inc., Shanghai, China) for 24 h, then changed to 1640 medium supplemented with 5% fetal bovine serum (FBS), 100 U ml^−1^ penicillin, 100 µg ml^−1^ streptomycin and 2 mM L-glutamine for 60 h^[@CR42]^.

Cell conditioned medium collection and ELISA assays {#Sec19}
---------------------------------------------------

Fifth-passage RIFs were cultured in α-MEM (without phenol red; Gibco) without FBS for 24 hours. Supernatants were collected and filtered with MILLEX-GP 0.22-μm filters (Merck Millipore Ltd. Co., Cork, Munster, Ireland) to remove cell debris and concentrated to 1% volume with Amicon Ultra-4 centrifugal ultrafiltration tubes (NMWL 3KDa) (Merck Millipore Ltd. Co.) for use as conditioned medium (CM).

The concentrations of IL-1β, IL-6, TNF-α and activated TGF-β1 in CM was detected by ELISA kits (R&D Systems Inc., Minneapolis, MN, USA) according to the manufacturer's instructions and assessed by densitometry analysis as previously described^[@CR56]^.

Color Doppler flow imaging of kidneys {#Sec20}
-------------------------------------

Five-week-old mice were anesthetized with 3% pentobarbital sodium at 40 mg kg^−1^ and depilated in abdominal region. Peak systolic velocity (PSV) of renal arteries was detected by a high frequency ultrasound imaging system for small animal research (Vevo 2100, Visualsonics, Toronto, ON, Canada) equipped with the MS-400 transducer of 24 MHz central frequency^[@CR14]^. Renal interlobular arteries were sampled by pulse Doppler for displaying blood vessels trees in renal cortex. More than three consistent morphological frames were obtained and frozen^[@CR14]^. Renal interlobular arteries in 3 different regions of renal cortex were detected for each kidney of each mouse^[@CR14],\ [@CR57],\ [@CR58]^.

Preparation of renal sections {#Sec21}
-----------------------------

Five-week-old mice were anesthetized with 3% pentobarbital sodium at 40 mg kg^−1^. Kidneys were perfused with 100 ml PBS (0.01 mM PO~4~ ^3−^, pH 7.4), perfused and fixed with periodate-lysine-paraformaldehyde (PLP) solution (4% paraformaldehyde containing 0.075 M lysine and 0.01 M sodium periodate) or 1% glutaraldehyde. Samples were cut into two identical pieces along the coronal axis and post fixed in PLP solution (for histochemistry or immunohistochemistry) or 1% glutaraldehyde (for conventional electron microscopy) overnight at 4 °C as previously described^[@CR14],\ [@CR20]^.

For histochemistry or immunohistochemistry, sections were dehydrated in a series of graded ethanol solutions, embedded in paraffin and cut into 5-μm sections on a rotary microtome (Leica Biosystems Nussloch GmbH, Nussloch, Germany). Renal cortex and medulla were trimmed, dehydrated and embedded in Epon 812 (CEM Corporation, Tokyo, Japan) for electron microscopy. Ultrathin sections (70 nm) were counterstained on copper grids with uranyl acetate and lead citrate, and examined with a JEOL 1200EX electron microscope (JEOL Ltd., Tokyo, Japan) as previously described^[@CR14],\ [@CR59]^.

Histology staining {#Sec22}
------------------

For histochemical or immunohistochemical staining, serial paraffin sections were deparaffinized and rehydrated in water. For cytochemical or immunocytochemical staining, cells seeded on chamber slides (Thermo Fisher Scientific, Rochester, NY, USA) were fixed with PLP solution for 45 minutes.

For cellular or pre-embedding SA-β-gal staining, cells or kidneys were washed three times for 30 min in LacZ wash buffer (2 mM MgCl~2~, 0.01% sodium deoxycholate, 0.02% nonidet-P40 in PBS, pH 6.0) following fixing for 2 hours in PLP^[@CR14],\ [@CR60]^. Staining was in 0.5 mg ml^−1^ X-gal, 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide (Sigma) in LacZ wash buffer at 37 °C overnight with shaking and protection from light as previously described^[@CR14],\ [@CR60]^.

For Masson's trichrome staining, serial paraffin sections were generated with D026 Masson detection kits according to the manufacturer's instructions (Nanjing Jiancheng Bioengineering Institute, Nanjing, Jiangsu, China) as previously described^[@CR14]^.

For immunohistochemical staining, serial paraffin sections were generated for antigen retrieval, steamed for 20 minutes in PBS (0.01 mM PO~4~ ^3−^, pH 7.4) followed by blocking of endogenous peroxidase (3% H~2~O~2~) and preincubation with serum as previously described^[@CR14]^. Primary antibodies against Ki67 (Abcam, Cambridge, MA, USA), 8-OHdG (Abcam), CD3 (Santa Cruz Biotechnology Inc., Dallas, TX, USA), F4/80 (Santa Cruz Biotechnology Inc.), IL-1β (Abcam), IL-6 (Santa Cruz Biotechnology Inc.), TNF-α (Santa Cruz Biotechnology Inc.), NF-κB-p65 (Cell Signaling Technology, Beverly, MA, USA), E-cadherin (Santa Cruz Biotechnology Inc.), activated TGF-β1 (Abcam), type Ι collagen (Southern Biotech, Birmingham, AL, USA), and α-SMA (Abcam) were used. After washing, sections were incubated with secondary antibody (biotinylated IgG; Sigma), washed and processed using Vectastain ABC-HRP kits (Vector Laboratories Inc., Burlingame, CA, USA). Sections were counterstained with hematoxylin and mounted with Biomount medium.

Immunocytochemical Staining {#Sec23}
---------------------------

Cells seeded on Lab-Tek®II Chamber Slide^TM^ system (Thermo Fisher Scientific Inc., Rochester, NY, USA) were fixed with PLP solution for 45 minutes^[@CR61]^.

For immunocytochemical staining, endogenous peroxidase was blocked with 3% H~2~O~2~ and cells were pre-incubated with serum^[@CR14],\ [@CR20]^. Primary antibody against α-SMA (Abcam) was used. After washing, cells were incubated with secondary antibody (biotinylated IgG; Sigma), washed, and processed using Vectastain ABC-HRP kits (Vector Laboratories Inc.). Cells were counterstained with hematoxylin and mounted with Biomount medium on slides as previously described^[@CR14],\ [@CR20]^.

For immunofluorescence, cells were pre-incubated with serum. Primary antibodies against α-SMA (Abcam) and affinity-purified Alexa Fluor 488-conjugated secondary antibody (Life Technologies Corporation, USA) were used. Nuclei were labeled with DAPI (Sigma-Aldrich, USA) and mounted with medium to prevent quenching (Vector Laboratories Inc., USA)^[@CR61]^.

TUNEL assays {#Sec24}
------------

Dewaxed and rehydrated paraffin sections were stained with *In Situ* Cell Death Detection Kits (Roche Diagnostics Corp., Basel, Switzerland) using a previously described protocol^[@CR20],\ [@CR60]^.

RNA isolation and real-time RT-PCR {#Sec25}
----------------------------------

RNA was isolated from kidneys of 5-week-old mice or HK2 cells using TRIzol reagent (Invitrogen Inc., Carlsbad, CA, USA) according to the manufacturer's protocol. Levels of mRNA in samples were quantified by real-time RT-PCR as previously described^[@CR14],\ [@CR60]^. Real-time RT-PCR primers are listed in Table [S2](#MOESM1){ref-type="media"}.

Western blots {#Sec26}
-------------

Kidneys from 5-week-old mice were dissected. Samples of kidneys and HK2 cells were immediately placed into RIPA lysis buffer (Lot P0013B) (Beyotime Institute of Biotechnology, Shanghai, China) containing a cocktail of proteinase inhibitors and phosphatase inhibitors (Roche Diagnostics Corp., Basel, Switzerland) for protein extraction as previously described^[@CR14]^. Protein extracts were boiled for 5 min in sample buffer, fractionated by SDS gel electrophoresis and transferred to nitrocellulose membranes. Membranes were blocked for 2 h at 37 °C with 5% nonfat dry milk in PBS/Tween 20^[@CR14]^. Blots were incubated overnight at 4 °C with antibodies against IL-1β (Abcam), IL-6 (Santa Cruz Biotechnology Inc.), TNF-α (Santa Cruz Biotechnology Inc.), NF-κB-p65 (Cell Signaling Technology), NF-κB-p65 (phospho T435) (Abcam), E-cadherin (Santa Cruz Biotechnology Inc.), α-SMA (Abcam), TGF-β1 precursor (Abcam), activated TGF-β1 (Abcam), TGF-βRII (Santa Cruz Biotechnology Inc.), Smad2 (Santa Cruz Biotechnology Inc.), pSmad2/3 (Ser 423/425) (Santa Cruz Biotechnology Inc.) or β-actin (Bioworld Technology, St. Louis Park, MN, USA), followed by incubation for 1 hour with HRP-conjugated secondary antibody (Sigma). Immunoreactive bands were visualized by enhanced chemiluminescence reagent treatment and exposure to ECL western blotting detection reagents (Amersham Pharmacia, Piscataway, NJ, USA). Band intensity was measured using Image-Pro Plus 5.0.1.9 software (Media Cybernetics inc., Rockville, MD, USA).

Biochemical Measurements {#Sec27}
------------------------

### Urinary creatinine and urea albumin {#Sec28}

Five-week-old mice were placed in metabolic cages the day before sacrificing and given water but not food. Urine was collected for 24 hours before sacrificing and used to measure UCr (C011 Cr detection kit) and UAL (A028 UAL detection kit) according to the manufacturer's instructions (Nanjing Jiancheng Bioengineering Institute, Nanjing, Jiangsu, China) as previously described^[@CR14],\ [@CR62]^.

### Serum urea nitrogen and serum creatinine {#Sec29}

Five-week-old mice were anesthetized with 3% pentobarbital sodium at 40 mg kg^−1^ and depilated in the abdominal region. Blood was taken by suction from the heart with a 1 ml syringe^[@CR14]^. Serum was isolated for measurements of SUN (C013-2 SUN detection kits) and SCr (C011 Cr detection kits) according to the manufacturer's instructions^[@CR14]^ (Nanjing Jiancheng Bioengineering Institute). Hominal SCrCl was analyzed by the Cockcroft Gault Equation^[@CR14],\ [@CR63]^:$$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
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                \begin{document}$${\rm{SCrCl}}=[(140-{\rm{age}})({\rm{year}})\ast {\rm{body}}\,{\rm{mass}}(kg)]/[0.818\ast {\rm{SCr}}(\mu \text{mol}/L)].$$\end{document}$$

The SCrCl level of *Bmi*-*1* ^−/−^ mice relative to the SCrCl level of WT littermates was assessed by a previously described equation^[@CR14]^:$$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
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                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$\begin{array}{c}[\text{Bmi}-{1}^{-/-}{\rm{body}}\,{\rm{mass}}(g)/\text{WT}\,{\rm{body}}\,{\rm{mass}}(g)]\ast {\rm{WT}}\,{\rm{SCr}}(\mu \text{mol}/L)/\text{Bmi}-{1}^{-/-}\\ \quad {\rm{SCr}}(\mu \text{mol}/L):1.\end{array}$$\end{document}$$

Hematocrit measurements {#Sec30}
-----------------------

Blood (20 μl) was collected in heparinized microhematocrit capillary tubes and spun at 3000 × *g* for 5 min at room temperature. Hematocrits were measured by a previously described equation^[@CR14],\ [@CR64]^:$$\documentclass[12pt]{minimal}
                \usepackage{amsmath}
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                \begin{document}$${\rm{Hematocrit}}( \% )=[{\rm{the}}\,{\rm{height}}\,{\rm{of}}\,{\rm{red}}\,{\rm{blood}}\,{\rm{cells}}(mm)]/[{\rm{the}}\,{\rm{height}}\,{\rm{of}}\,{\rm{whole}}\,{\rm{blood}}(mm)].$$\end{document}$$

Statistical analysis {#Sec31}
--------------------

All analyses were performed using SPSS software (Version 19.0; SPSS Inc., Chicago, IL, USA) as previously described^[@CR14]^. Measurement data were described as mean ± SEM fold-change over control and analyzed by Student's *t*-test and one-way ANOVA to compare differences among groups. Qualitative data were described as percentages and analyzed using chi-square tests as indicated. P-values were two-sided and less than 0.05 was considered statistically significant.
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